Prevention of disease progression throughout the cardiovascular continuum :
General Material Designation
[Book]
Other Title Information
the.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
[Place of publication not identified]
Name of Publisher, Distributor, etc.
Springer
Date of Publication, Distribution, etc.
2013
CONTENTS NOTE
Text of Note
1 The Cardiovascular Continuum - Pathophysiology and Targets for Therapy.- 2 Anti-Adrenergic Therapy in Hypertensive Patients with Concomitant Disease.- 3 The Effects of ss-Blockade on the Cardiovascular System - Not All ss-Blockers are Created Equal.- 4 The Role of Multiple Adrenergic Blockade in Coronary Artery Disease and Myocardial Infarction.- 5 Epidemiology and Problems with Diagnosis of Heart Failure.- 6 The Future of the Diagnosis of Left Ventricular Dysfunction and Heart Failure.- 7 Are All ss-Blockers the Same for Heart Failure? Insights from Clinical Trials and Future Research Directions.- 8 The Therapeutic Role of ss-Adrenoceptor-Blocking Agents in Severe Heart Failure.- 9 Tolerability of Anti-Adrenergic Treatment of Congestive Heart Failure in Daily Practice.- 10 Adrenergic Blockade in Heart Failure - Official Guidelines and Practical Recommendations on Optimal Use.- 11 The Future of Heart Failure Management.